-
Gilead: Remdesivir sold $1.93 billion in Q4
In the early days of the COVID-19 pandemic, when researchers scrambled to find drugs that could treat this new type of disease, Gilead Sciences compan...
2021-02-08 14:03 -
Global AIDS drug market: Bituwei grows into a leading product
On February 3 and 4, GlaxoSmithKline and Gilead announced their 2020 annual results. Since AIDS is a very important business area for the two companie...
2021-02-07 17:58 -
China's pharmaceutical exports to Brazil increase by 197% in 2020
According to global customs statistics, in 2020, China's drug exports to Brazil were US$449 million, a significant year-on-year increase of 197.35%, m...
2021-02-07 12:01 -
Novo Nordisk expands production of raw materials/development of oral drugs
On Wednesday, Novo Nordisk said that it expects to invest about 8 billion Danish kroner (about 1.3 billion US dollars) in capital projects in 2021 to ...
2021-02-05 15:26 -
About Sinopep-Allsino Biopharmaceutical Co Ltd.
Sinopep is a market-oriented and innovation-driven biopharmaceutical company. The company is focusing on the R&D, manufacturing and sales of pharmaceu...
2021-02-04 17:31 -
Clinical Trials Experience of Liraglutide in Weight-Loss
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be dire...
2021-02-04 14:45 -
Clinical Trials Experience of Liraglutide in Type 2 Diabetes
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be dire...
2021-02-04 14:05 -
Global Liraglutide Market Trends
Liraglutide formulation was first approved by the U.S. Food and Drug Administration in 2010 and accounted for $418 million in sales that year. By the ...
2021-02-04 13:39 -
Liraglutide for Weight Loss
Liraglutide is an acylated human glucagon-like peptide-1 (GLP-1) receptor agonist with 97% amino acid sequence homology to endogenous human GLP-1(7-37...
2021-02-04 11:38 -
Liraglutide in the management of type 2 diabetes
Liraglutide is an acylated human Glucagon-Like Peptide-1 (GLP-1) receptor agonist with 97% amino acid sequence homology to endogenous human GLP-1(7-37...
2021-02-04 11:26
Hot News
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Europe Faces Unprecedented Pet... Jul 23, 2025
- BASF Launches Second Round of ... Jul 24, 2025
- Guangdong Jieyang Puts into Op... Jul 16, 2025
Related Products
Related Producers
